Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Engage Grants Program

Dalhousie University

$24,945.00

Membrane Optimization for Anesthesia CO2 Separation Device

FY 2012-13

Summary
DMF Medical Inc., a Nova Scotia based corporation, has developed a new, membrane based CO2 removal device for anesthesia circuits called ZeroSorb. A CO2 removal device is mandatory for two thirds of all operations performed under general anesthesia. The new device operates in a manner similar to existing CO2 removal devices except that, unlike existing devices, it does not react to create toxic by-products when contacted with anesthetic gases. These toxic by-products are inhaled by patients undergoing anesthesia and are linked to a condition known as Post Operative Decline (POCD). This project will investigate and optimize the design of the ZeroSorb device for its ability to to perform industry-leading, safe, CO2 removal in anesthesia circuits. During the project, alternative configurations of the device will be investigated to arrive at an optimal design. DMF Medical Inc. will then produce prototype quantities of the device for testing in clinical trials and acquiring regulatory approval. The product will then be commercialized for sale world-wide.
Program
Engage Grants Program
Location
Nova Scotia, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data

As published

Application id
434531-2012
Name nom
Haelssig, Jan
Department département
Process Engineering and Applied Science
Organization id
79
Institution établissement
Dalhousie University
Province en
Nova Scotia
Province fr
Nouvelle-Écosse
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2012
Competition year année de concours
2012
Award amount
24945
Program id
EGP
Program name en
Engage Grants Program
Program name fr
Programme de subventions d'engagement partenariat
Group en
Research partnerships programs
Group fr
Programmes de partenariat
Committee code
1551
Committee name en
Atlantic Internal Decision Committee
Committee name fr
Comité de décision interne pour l'Atlantique
Area of application code
518
Area of application group en
Manufacturing processes and products
Area of application group fr
Procédés et produits industriels
Area of application en
Medical equipment and apparatus
Area of application fr
Appareils et instruments médicaux
Research subject code
1901
Research subject group en
Biomedical engineering
Research subject group fr
Génie biomédical
Research subject en
Biomedical technology
Research subject fr
Technologie biomédicale
Partie
1
Nb partie
1
Application title
Membrane Optimization for Anesthesia CO2 Separation Device
Keyword
NSERC
Application summary
DMF Medical Inc., a Nova Scotia based corporation, has developed a new, membrane based CO2 removal device for anesthesia circuits called ZeroSorb. A CO2 removal device is mandatory for two thirds of all operations performed under general anesthesia. The new device operates in a manner similar to existing CO2 removal devices except that, unlike existing devices, it does not react to create toxic by-products when contacted with anesthetic gases. These toxic by-products are inhaled by patients undergoing anesthesia and are linked to a condition known as Post Operative Decline (POCD). This project will investigate and optimize the design of the ZeroSorb device for its ability to to perform industry-leading, safe, CO2 removal in anesthesia circuits. During the project, alternative configurations of the device will be investigated to arrive at an optimal design. DMF Medical Inc. will then produce prototype quantities of the device for testing in clinical trials and acquiring regulatory approval. The product will then be commercialized for sale world-wide.